A Multicenter Extension Trial to Evaluate the Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males [EXTENSION OF 700221932]
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Apr 2013 New trial record
- 06 Dec 2012 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.